epofolate
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2007 (NCT00550017)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Folate receptor alphaBINDING AGENT
FOLR1 binding agent
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Payload
- epothilone
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297749 ↗
Also known as
- bms-753493
- bms-753493
- epofolate
- epofolate
- epofolate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00546247 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2008 | Bristol-Myers Squibb |
| NCT00550017 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2007 | Bristol-Myers Squibb |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 2 | 2 | 1 | 2007 |
1 organizations
Page 1 / 1